The changing pattern of methicillin-resistant Staphylococcus aureus clones in latin America: Implications for clinical practice in the region

Brazilian Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 2, 2010, Pages

  Rodríguez Noriega, Eduardo ^a   Seas, Carlos ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Clones; Latin america; Molecular epidemiology; Mrsa

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAM; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GLYCOPEPTIDE; LINCOSAMIDE; LINEZOLID; MACROLIDE; QUINOLONE; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BRAZIL; CHILE; CLINICAL PRACTICE; HOSPITAL INFECTION; HUMAN; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; NONHUMAN; SKIN INFECTION; SOFT TISSUE INFECTION; SOUTH AND CENTRAL AMERICA; UNITED STATES;

EID: 78650803415     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000800004     Document Type: Article

References (87)

1. Guzmán-Blanco M, Mejía C, Isturiz R et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents. 2009; 34(4):304-8.
2. Rodríguez-Noriega E, Seas C, Guzmán-Blanco M et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010; 14:e560-6.
3. Ito T, Ma XX, Takeuchi F et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004; 48(7):2637-51.
4. Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet. 1963; 1(7287):904-7.
5. Crisostomo MI, Westh H, Tomasz A et al. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci U S A. 2001; 98(17):9865-70.
6. Deurenberg RH, Stobberingh EE. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med. 2009; 9(2):100-15.
7. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol. 2008; 8(6):747-63.
8. Donnio PY, Fevrier F, Bifani P et al. Molecular and epidemiological evidence for spread of multiresistant methicillin-susceptible Staphylococcus aureus strains in hospitals. Antimicrob Agents Chemother. 2007; 51(12):4342-50.
9. Cookson BD, Robinson DA, Monk AB et al. Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol. 2007; 45(6):1830-7.
10. Naimi TS, LeDell KH, Como-Sabetti K et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290(22):2976-84.
11. Gorwitz RJ. Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. J Infect Dis. 2008; 197(2):179-82.
12. Flynn N, Cohen SH. The continuing saga of MRSA. J Infect Dis. 2008; 197(9):1217-9.
13. Ayliffe GA. The progressive intercontinental spread of methicillin- resistant Staphylococcus aureus. Clin Infect Dis. 1997; 24(Suppl 1):S74-9.
14. Robinson DA, Enright MC. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2004; 10(2):92-7.
15. Denis O, Deplano A, Nonhoff C et al. National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones. Antimicrob Agents Chemother. 2004; 48(9):3625-9.
16. Aires-de-Sousa M, Correia B, de Lencastre H. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period. J Clin Microbiol. 2008; 46(9):2912-7.
17. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis. 2002; 2(3):180-9.
18. Musser JM, Kapur V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol. 1992; 30(8):2058-63.
19. Potel C, Alvarez M, Alvarez P et al. Evolution, antimicrobial susceptibility and assignment to international clones of methicillinresistant Staphylococcus aureus isolated over a 9-year period in two Spanish hospitals. Clin Microbiol Infect. 2007; 13(7):728-30.
20. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008; 46(6):787-94.
21. Sader HS, Pignatari AC, Hollis RJ, Jones RN. Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA. Infect Control Hosp Epidemiol. 1994; 15(5):320-3.
22. Aires de Sousa M, Miragaia M, Sanches IS et al. Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol. 2001; 39(6):2197-205.
23. Sola C, Gribaudo G, Vindel A et al. Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Cordoba, Argentina, involved in nosocomial infections. J Clin Microbiol. 2002; 40(4):1427-35.
24. Velazquez-Meza ME, Aires de Sousa M, Echaniz-Aviles G et al. Surveillance of methicillin-resistant Staphylococcus aureus in a pediatric hospital in Mexico City during a 7-year period (1997 to 2003): clonal evolution and impact of infection control. J Clin Microbiol. 2004; 42(8):3877-80.
25. Akpaka PE, Kissoon S, Rutherford C et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from regional hospitals in Trinidad and Tobago. Int J Infect Dis. 2007; 11(6):544-8.
26. Amaral MM, Coelho LR, Flores RP et al. The predominant variant of the Brazilian epidemic clonal complex of methicillin- resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells. J Infect Dis. 2005; 192(5):801-10.
27. Cruz C, Moreno J, Renzoni A et al. Tracking methicillin-resistant Staphylococcus aureus clones in Colombian hospitals over 7 years (1996-2003): emergence of a new dominant clone. Int J Antimicrob Agents. 2005; 26(6):457-62.
28. Echaniz-Aviles G, Velazquez-Meza ME, Aires-de-Sousa M et al. Molecular characterisation of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone in a Mexican hospital (1999-2003). Clin Microbiol Infect. 2006; 12(1):22-8.
29. Goering RV, Shawar RM, Scangarella NE et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol. 2008; 46(9):2842-7.
30. Gomes AR, Sanches IS, Aires de Sousa M et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Colombian hospitals: dominance of a single unique multidrug- resistant clone. Microb Drug Resist. 2001; 7(1):23-32.
31. Ramirez Barba EJ, Rosenthal VD, Higuera F et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control. 2006; 34(4):244-7.
32. Mayor L, Ortellado J, Menacho C et al. Molecular characterization of methicillin-resistant Staphylococcus aureus isolates collected in Asuncion, Paraguay. J Clin Microbiol. 2007; 45(7):2298-300.
33. Melo MC, Silva-Carvalho MC, Ferreira RL et al. Detection and molecular characterization of a gentamicin-susceptible, methicillin-resistant Staphylococcus aureus (MRSA) clone in Rio de Janeiro that resembles the New York/Japanese clone. J Hosp Infect. 2004; 58(4):276-85.
34. Ribeiro A, Dias C, Silva-Carvalho MC et al. First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America. J Clin Microbiol. 2005; 43(4):1985-8.
35. Sola C, Saka HA, Vindel A, Bocco JL. Emergence and dissemination of a community-associated methicillin-resistant Panton-Valentine leucocidin-positive Staphylococcus aureus clone sharing the sequence type 5 lineage with the most prevalent nosocomial clone in the same region of Argentina. J Clin Microbiol. 2008; 46(5):1826-31.
36. Reyes J, Rincon S, Diaz L et al. Dissemination of methicillinresistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis. 2009; 49(12):1861-7.
37. Ma XX, Galiana A, Pedreira W et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis. 2005; 11(6):973-6.
38. Ramos RL, Teixeira LA, Ormonde LR et al. Emergence of mupirocin resistance in multiresistant Staphylococcus aureus clinical isolates belonging to Brazilian epidemic clone III::B:A. J Med Microbiol. 1999; 48(3):303-7.
39. Corso A, Santos Sanches I, Aires de Sousa M et al. Spread of a methicillin-resistant and multiresistant epidemic clone of Staphylococcus aureus in Argentina. Microb Drug Resist. 1998; 4(4):277-88.
40. Seas C, Hernandez K, Ramos R et al. Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru. Infect Control Hosp Epidemiol. 2006; 27(2):198-200.
41. Pfizer Venezuela S.A. Venezuelan program of surveillance of bacterial resistance to antibiotics; 1998-2006. (http://www.provenra.org) Accessed 19 May 2010.
42. Aylwin M, Serri M, Gracía P et al. Staphylococcus aureus meticilino resistente asociado a la comunidad en Chile (A-C021). Abstract presented at the XXIV Chilean Conference of Infectious Diseases. Pucón, Chile, 2007.
43. Noríega LM, Gonzalez P, Hormazabal JC et al. Community acquired infections with methicillin resistant strains of Staphylococcus aureus: report of five cases. Rev Med Chil. 2008; 136(7):885-91.
44. Diep BA, Carleton HA, Chang RF et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006; 193(11):1495-503.
45. Diep BA, Palazzolo-Ballance AM, Tattevin P et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One. 2008; 3(9):e3198.
46. Diep BA, Sensabaugh GF, Somboona NS et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol. 2004; 42(5):2080-4.
47. Francis JS, Doherty MC, Lopatin U et al. Severe communityonset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005; 40(1):100-7.
48. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006; 355(7):666-74.
49. Limbago B, Fosheim GE, Schoonover V et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol. 2009; 47(5):1344-51.
50. McCaskill ML, Mason EO, Jr., Kaplan SL et al. Increase of the USA300 clone among community-acquired methicillinsusceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007; 26(12):1122-7.
51. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton- Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999; 29(5):1128-32.
52. Gillet Y, Issartel B, Vanhems P et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002; 359(9308):753-9.
53. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton- Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis. 2007; 13(4):594-600.
54. Vivoni AM, Diep BA, de Gouveia Magalhaes AC et al. Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital: identification of international circulating lineages. J Clin Microbiol. 2006; 44(5):1686-91.
55. Sola C, Saka HA, Vindel A, Bocco JL. High frequency of Panton- Valentine leukocidin genes in invasive methicillin-susceptible Staphylococcus aureus strains and the relationship with methicillin-resistant Staphylococcus aureus in Cordoba, Argentina. Eur J Clin Microbiol Infect Dis. 2007; 26(4):281-6.
56. Souza RR, Coelho LR, Botelho AM et al. Biofilm formation and prevalence of lukF-pv, seb, sec and tst genes among hospital- and community-acquired isolates of some international methicillin-resistant Staphylococcus aureus lineages. Clin Microbiol Infect. 2009; 15(2):203-7.
57. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Med. 2006; 119(6 Suppl 1):S11-9; discussion S62-70.
58. Deurenberg RH, Vink C, Kalenic S et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2007; 13(3):222-35.
59. Chang S, Sievert DM, Hageman JC et al. Infection with vancomycin- resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003; 348(14):1342-7.
60. Tenover FC, Moellering RC, Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007; 44(9):1208-15.
61. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulasenegative staphylococci. J Clin Microbiol. 2003; 41(10):4740-4.
62. Patel M, Waites KB, Moser SA et al. Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol. 2006; 44(7):2481-4.
63. Chavez-Bueno S, Bozdogan B, Katz K et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005; 49(6):2283-8.
64. Vivoni AM, Santos KR, de-Oliveira MP et al. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp Epidemiol. 2005; 26(7):662-7.
65. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med. 2008; 121(4):310-5.
66. Saiman L, Cronquist A, Wu F et al. An outbreak of methicillin- resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003; 24(5):317-21.
67. de A Trindade P, Pacheco RL, Costa SF et al. Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin- resistant Staphylococcus aureus. J Clin Microbiol. 2005; 43(7):3435-7.
68. de Miranda OP, Silva-Carvalho MC, Ribeiro A et al. Emergence in Brazil of methicillin-resistant Staphylococcus aureus isolates carrying SCCmecIV that are related genetically to the USA800 clone. Clin Microbiol Infect. 2007; 13(12):1165-72.
69. Lamaro-Cardoso J, Castanheira M, de Oliveira RM et al. Carriage of methicillin-resistant Staphylococcus aureus in children in Brazil. Diagn Microbiol Infect Dis. 2007; 57(4):467-70.
70. Hidron AI, Kourbatova EV, Halvosa JS et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005; 41(2):159-66.
71. Cespedes C, Said-Salim B, Miller M et al. The clonality of Staphylococcus aureus nasal carriage. J Infect Dis. 2005; 191(3):444-52.
72. Pan ES, Diep BA, Charlebois ED et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus- and their relation to community-associated disease activity. J Infect Dis. 2005; 192(5):811-8.
73. Lamaro-Cardoso J, de Lencastre H, Kipnis A et al. Molecular epidemiology and risk factors for nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in infants attending day-care centers in Brazil. J Clin Microbiol. 2009; 47(12):3991-7.
74. von Eiff C, Becker K, Machka K et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001; 344(1):11-6.
75. Robicsek A, Suseno M, Beaumont JL et al. Prediction of methicillin- resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol. 2008; 46(2):588-92.
76. Cespedes C, Miller M, Quagliarello B et al. Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol. 2002; 40(7):2594-7.
77. Eveillard M, Martin Y, Hidri N et al. Carriage of methicillinresistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol. 2004; 25(2):114-20.
78. Awad SS, Elhabash SI, Lee L et al. Increasing incidence of methicillin- resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg. 2007; 194(5):606-10.
79. Bhattacharya D, Carleton H, Tsai CJ et al. Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California. J Clin Microbiol. 2007; 45(6):1798-803.
80. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis. 2004; 50(1):59-69.
81. Fowler VG, Jr., Miro JM, Hoen B et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005; 293(24):3012-21.
82. Corey GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis. 2009; 48 (Suppl 4):S254-9.
83. Ganga R, Riederer K, Sharma M et al. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center. J Clin Microbiol. 2009; 47(3):590-5.
84. Fortes CQ, Espanha CA, Bustorff FP et al. First reported case of infective endocarditis caused by community-acquired methicillin- resistant Staphylococcus aureus not associated with healthcare contact in Brazil. Braz J Infect Dis. 2008; 12(6):541-3.
85. Lee SY, Kim JY, Kim JH et al. A case of primary infective endocarditis caused by community-associated methicillin-resistant Staphylococcus aureus in a healthy individual and colonization in the family. Yonsei Med J. 2009; 50(1):152-5.
86. Aires de Sousa M, Sanches IS, Ferro ML et al. Intercontinental spread of a multidrug-resistant methicillin-resistant Staphylococcus aureus clone. J Clin Microbiol. 1998; 36(9):2590-6.
87. Shopsin B, Mathema B, Zhao X et al. Resistance rather than virulence selects for the clonal spread of methicillin-resistant Staphylococcus aureus: implications for MRSA transmission. Microb Drug Resist. 2000; 6(3):239-44.